
By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed
Advertisement
Articles by By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Centanafadine's Route to FDA Review: A Clinical Path of the ADHD Medication
2
2026 Conference Insights: ASCP
3
Underdiagnosed and Undertreated: Verena Ramirez Campos, MD, on Tardive Dyskinesia Care
4
Brain Trust: The Placebo Effect as a Clinical Tool, A Discussion With Walter A. Brown, MD
5

